$500m fine over generics fraud for Ranbaxy
23 May 2013 Business
Company has pleaded guilty to fabricating data and producing substandard drugs
Digitally unrolling historical scrolls
22 May 2013 Research
X-ray tomography can unroll and read parchment scrolls that have become stuck together.
News
Egyptian research budget ‘unspent’
23 May 2013 News and Analysis
Egypt's ministry of scientific research faces funding cuts, after failing to spend most of this year's budget.
The power of multivalency against cholera
Inhibitor combines a pentavalent scaffold with cell membrane sugar to trick and trap the c...
Understanding sulfa drugs' side effects
Over 70 years since their first use, scientists discover how sulfanonamide drugs cause the...
US Supreme Court rules in favour of Monsanto
An Indiana farmer who was trying to replicate Monsanto-patented seeds infringed on the com...
Lords Bill proposes animal research labelling for medicines
Bill aims to underline the necessity of animal experiments, says Robert Winston
B-vitamins may delay Alzheimer’s onset
Taking B-vitamins keeps brain tissue healthier for longer, and may help stave off dementia
Features
Survival in the freezer
2 May 2013 
Feature
How do animals survive in the extreme cold? James Mitchell Crow investigates
Lean green microbe machines
For its proponents, algae hold the promise of a clean source of fuel, food or drugs. Antho...
What does DNA do?
The more we learn about DNA, the less we seem to know, as Philip Ball discovers
Podcasts
The Chemistry World Podcast
Monthly news, interviews and discussions on the latest topics in science
Chemistry in its element: compounds
Each week a leading scientist or author tells the story behind a different compound
Blog
Pint of science
23 May 2013
More than just camouflage
20 May 2013
Online Media Awards 2013 – Finalists
15 May 2013
Opinions
Comments
Compulsory licences: necessity or threat?
Are compulsory licences for patent-protected drugs a necessary measure, or a threat to innovation?
The Crucible
The name's (quadruple) bond?
Philip Ball discusses the contentious issue of C2 bonding. Dare we draw four lines?
